Invesco’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-75,282
| Closed | -$1.52M | – | 3883 |
|
|
2026
Q1 | $1.52M | Sell |
75,282
-2,582
| -3% | -$41.6K | ﹤0.01% | 2675 |
|
|
2025
Q4 | $1.26M | Buy |
77,864
+14,621
| +23% | +$194K | ﹤0.01% | 2810 |
|
|
2025
Q3 | $770K | Buy |
63,243
+12,482
| +25% | +$172K | ﹤0.01% | 3045 |
|
|
2025
Q2 | $574K | Buy |
50,761
+10,957
| +28% | +$134K | ﹤0.01% | 3102 |
|
|
2025
Q1 | $459K | Buy |
39,804
+24,164
| +155% | +$247K | ﹤0.01% | 3184 |
|
|
2024
Q4 | $132K | Buy |
15,640
+1,083
| +7% | +$11.2K | ﹤0.01% | 3588 |
|
|
2024
Q3 | $169K | Buy |
14,557
+277
| +2% | +$3.48K | ﹤0.01% | 3549 |
|
|
2024
Q2 | $168K | Buy |
14,280
+308
| +2% | +$3.59K | ﹤0.01% | 3668 |
|
|
2024
Q1 | $166K | Buy |
13,972
+495
| +4% | +$6.6K | ﹤0.01% | 3682 |
|
|
2023
Q4 | $165K | Buy |
+13,477
| New | +$123K | ﹤0.01% | 3600 |
|
|
2023
Q2 | – | Sell |
-10,147
| Closed | -$79.8K | – | 3899 |
|
|
2023
Q1 | $79.8K | Sell |
10,147
-1,071
| -10% | -$7.99K | ﹤0.01% | 3721 |
|
|
2022
Q4 | $75.8K | Buy |
+11,218
| New | +$60.1K | ﹤0.01% | 3863 |
|
|
2021
Q4 | – | Sell |
-10,222
| Closed | -$178K | – | 4072 |
|
|
2021
Q3 | $178K | Sell |
10,222
-145,618
| -93% | -$2.95M | ﹤0.01% | 3839 |
|
|
2021
Q2 | $3.73M | Buy |
+155,840
| New | +$4.08M | ﹤0.01% | 2574 |
|
|
2020
Q2 | – | Sell |
-10,884
| Closed | -$83K | – | 3666 |
|
|
2020
Q1 | $83K | Buy |
+10,884
| New | +$147K | ﹤0.01% | 3583 |
|
|
2019
Q4 | – | Sell |
-11,257
| Closed | -$130K | – | 3672 |
|
|
2019
Q3 | $130K | Sell |
11,257
-247,416
| -96% | -$4M | ﹤0.01% | 3608 |
|
|
2019
Q2 | $5.73M | Sell |
258,673
-55,118
| -18% | -$1.29M | ﹤0.01% | 2097 |
|
|
2019
Q1 | $8.98M | Buy |
313,791
+37,268
| +13% | +$808K | ﹤0.01% | 1641 |
|
|
2018
Q4 | $5.46M | Buy |
+276,523
| New | +$5.56M | ﹤0.01% | 1886 |
|
|
2015
Q3 | – | Sell |
-54
| Closed | -$5K | – | 3888 |
|
|
2015
Q2 | $5K | Buy |
+54
| New | +$5.36K | ﹤0.01% | 4202 |
|
Other funds holding KALV
Invesco's KALV Position: Q2 2026 in Review
Invesco sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 75,282 shares — an estimated $1.52M sold.
Invesco first reported a position in KALV in Q2 2015 and held it in 20 quarters. The position peaked at $8.98M in Q1 2019. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.
- Invesco reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Invesco sold 75,282 KalVista Pharmaceuticals shares in Q2 2026, an estimated $1.52M.
- Invesco first reported a position in KalVista Pharmaceuticals in Q2 2015 and held it in 20 quarters.
- Invesco's KalVista Pharmaceuticals position peaked at $8.98M in Q1 2019.
- 1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.